Avantor, Inc. Financing Cash Flow
Avantor, Inc. (AVTR) reported Financing Cash Flow of -$107.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-04-29
- Avantor, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$107.20M.
- Avantor, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $700.00K.
- Avantor, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$369.60M.
- Avantor, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was -$6.90M.
- Avantor, Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$409.40M.
- Avantor, Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$1.28B.
- Avantor, Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$843.70M.
- Avantor, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$648.70M, a 120.15% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$107.20M 10-Q · filed 2026-04-29 | -$106.50M derived: sum of 2 quarters · filed 2026-04-29 | -$476.10M derived: sum of 3 quarters · filed 2026-04-29 | -$483.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$368.90M derived: sum of 2 quarters · filed 2026-02-11 | -$375.80M derived: sum of 3 quarters · filed 2026-02-11 | -$409.40M 10-K · filed 2026-02-11 |
| 2025-09-30 | -$369.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$376.50M derived: sum of 2 quarters · filed 2025-10-29 | -$410.10M 10-Q · filed 2025-10-29 | -$1.17B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | -$6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$40.50M 10-Q · filed 2025-08-01 | -$795.80M derived: sum of 3 quarters · filed 2026-04-29 | -$994.40M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | -$33.60M 10-Q · filed 2026-04-29 | -$788.90M derived: sum of 2 quarters · filed 2026-04-29 | -$987.50M derived: sum of 3 quarters · filed 2026-04-29 | -$1.18B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$755.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$953.90M derived: sum of 2 quarters · filed 2026-02-11 | -$1.15B derived: sum of 3 quarters · filed 2026-02-11 | -$1.28B 10-K · filed 2026-02-11 |
| 2024-09-30 | -$198.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$395.70M derived: sum of 2 quarters · filed 2025-10-29 | -$525.90M 10-Q · filed 2025-10-29 | -$710.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -$197.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$327.30M 10-Q · filed 2025-08-01 | -$511.40M derived: sum of 3 quarters · filed 2026-02-11 | -$699.80M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -$130.20M 10-Q · filed 2025-04-25 | -$314.30M derived: sum of 2 quarters · filed 2026-02-11 | -$502.70M derived: sum of 3 quarters · filed 2026-02-11 | -$698.90M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -$184.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$372.50M derived: sum of 2 quarters · filed 2026-02-11 | -$568.70M derived: sum of 3 quarters · filed 2026-02-11 | -$843.70M 10-K · filed 2026-02-11 |
| 2023-09-30 | -$188.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | -$384.60M derived: sum of 2 quarters · filed 2024-10-25 | -$659.60M 10-Q · filed 2024-10-25 | -$741.20M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | -$196.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | -$471.20M 10-Q · filed 2024-07-26 | -$552.80M derived: sum of 3 quarters · filed 2025-02-07 | -$772.20M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | -$275.00M 10-Q · filed 2024-04-26 | -$356.60M derived: sum of 2 quarters · filed 2025-02-07 | -$576.00M derived: sum of 3 quarters · filed 2025-02-07 | -$796.50M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | -$81.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | -$301.00M derived: sum of 2 quarters · filed 2025-02-07 | -$521.50M derived: sum of 3 quarters · filed 2025-02-07 | -$648.70M 10-K · filed 2025-02-07 |
| 2022-09-30 | -$219.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$439.90M derived: sum of 2 quarters · filed 2023-10-27 | -$567.10M 10-Q · filed 2023-10-27 | $893.90M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$220.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | -$347.70M 10-Q · filed 2023-07-28 | $1.11B derived: sum of 3 quarters · filed 2024-02-14 | $2.09B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | -$127.20M 10-Q · filed 2023-04-28 | $1.33B derived: sum of 2 quarters · filed 2024-02-14 | $2.31B derived: sum of 3 quarters · filed 2024-02-14 | $3.31B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $1.46B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $2.44B derived: sum of 2 quarters · filed 2024-02-14 | $3.44B derived: sum of 3 quarters · filed 2024-02-14 | $3.22B 10-K · filed 2024-02-14 |
| 2021-09-30 | $980.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $1.98B derived: sum of 2 quarters · filed 2022-10-28 | $1.76B 10-Q · filed 2022-10-28 | $1.38B derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $998.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $777.80M 10-Q · filed 2022-07-29 | $397.40M derived: sum of 3 quarters · filed 2023-02-14 | $81.30M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$221.00M 10-Q · filed 2022-04-29 | -$601.40M derived: sum of 2 quarters · filed 2023-02-14 | -$917.50M derived: sum of 3 quarters · filed 2023-02-14 | -$930.80M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$380.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$696.50M derived: sum of 2 quarters · filed 2023-02-14 | -$709.80M derived: sum of 3 quarters · filed 2023-02-14 | -$782.90M 10-K · filed 2023-02-14 |
| 2020-09-30 | -$316.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$329.40M derived: sum of 2 quarters · filed 2021-10-29 | -$402.50M 10-Q · filed 2021-10-29 | -$469.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | -$13.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$86.40M 10-Q · filed 2021-07-30 | -$153.80M derived: sum of 3 quarters · filed 2022-02-11 | -$326.40M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | -$73.10M 10-Q · filed 2021-04-28 | -$140.50M derived: sum of 2 quarters · filed 2022-02-11 | -$313.10M derived: sum of 3 quarters · filed 2022-02-11 | -$274.80M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | -$67.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$240.00M derived: sum of 2 quarters · filed 2022-02-11 | -$201.70M derived: sum of 3 quarters · filed 2022-02-11 | -$307.80M 10-K · filed 2022-02-11 |
| 2019-09-30 | -$172.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | -$134.30M derived: sum of 2 quarters · filed 2020-10-27 | -$240.40M 10-Q · filed 2020-10-27 | -$294.80M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $38.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$67.80M 10-Q · filed 2020-07-29 | -$122.20M derived: sum of 3 quarters · filed 2021-02-16 | -$188.40M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | -$106.10M 10-Q · filed 2020-04-29 | -$160.50M derived: sum of 2 quarters · filed 2021-02-16 | -$226.70M derived: sum of 3 quarters · filed 2021-02-16 | |
| 2018-12-31 | -$54.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$120.60M derived: sum of 2 quarters · filed 2021-02-16 | -$170.30M 10-K · filed 2021-02-16 | |
| 2018-09-30 | -$66.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$115.90M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | -$49.70M 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | $6.96B 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |